189 related articles for article (PubMed ID: 3581062)
1. Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor.
Henderson BW; Fingar VH
Cancer Res; 1987 Jun; 47(12):3110-4. PubMed ID: 3581062
[TBL] [Abstract][Full Text] [Related]
2. Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy.
Henderson BW; Waldow SM; Mang TS; Potter WR; Malone PB; Dougherty TJ
Cancer Res; 1985 Feb; 45(2):572-6. PubMed ID: 3967232
[TBL] [Abstract][Full Text] [Related]
3. Modification of photodynamic therapy-induced hypoxia by fluosol-DA (20%) and carbogen breathing in mice.
Fingar VH; Mang TS; Henderson BW
Cancer Res; 1988 Jun; 48(12):3350-4. PubMed ID: 3130983
[TBL] [Abstract][Full Text] [Related]
4. Oxygen limitation of direct tumor cell kill during photodynamic treatment of a murine tumor model.
Henderson BW; Fingar VH
Photochem Photobiol; 1989 Mar; 49(3):299-304. PubMed ID: 2525260
[TBL] [Abstract][Full Text] [Related]
5. Depletion of tumor oxygenation during photodynamic therapy: detection by the hypoxia marker EF3 [2-(2-nitroimidazol-1[H]-yl)-N-(3,3,3-trifluoropropyl)acetamide ].
Busch TM; Hahn SM; Evans SM; Koch CJ
Cancer Res; 2000 May; 60(10):2636-42. PubMed ID: 10825135
[TBL] [Abstract][Full Text] [Related]
6. Implications of a pre-existing tumor hypoxic fraction on photodynamic therapy.
Fingar VH; Wieman TJ; Park YJ; Henderson BW
J Surg Res; 1992 Nov; 53(5):524-8. PubMed ID: 1434604
[TBL] [Abstract][Full Text] [Related]
7. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.
Bellnier DA; Gollnick SO; Camacho SH; Greco WR; Cheney RT
Cancer Res; 2003 Nov; 63(22):7584-90. PubMed ID: 14633671
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy with verteporfin in the radiation-induced fibrosarcoma-1 tumor causes enhanced radiation sensitivity.
Pogue BW; O'Hara JA; Demidenko E; Wilmot CM; Goodwin IA; Chen B; Swartz HM; Hasan T
Cancer Res; 2003 Mar; 63(5):1025-33. PubMed ID: 12615718
[TBL] [Abstract][Full Text] [Related]
9. Novel photodynamic effects of a benzophenothiazine on two different murine sarcomas.
Cincotta L; Foley JW; MacEachern T; Lampros E; Cincotta AH
Cancer Res; 1994 Mar; 54(5):1249-58. PubMed ID: 8118813
[TBL] [Abstract][Full Text] [Related]
10. The effect of fluence rate on tumor and normal tissue responses to photodynamic therapy.
Sitnik TM; Henderson BW
Photochem Photobiol; 1998 Apr; 67(4):462-6. PubMed ID: 9559590
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of photodynamic therapy antitumor activity in mice by nitric oxide synthase inhibition is fluence rate dependent.
Henderson BW; Sitnik-Busch TM; Vaughan LA
Photochem Photobiol; 1999 Jul; 70(1):64-71. PubMed ID: 10420844
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy creates fluence rate-dependent gradients in the intratumoral spatial distribution of oxygen.
Busch TM; Wileyto EP; Emanuele MJ; Del Piero F; Marconato L; Glatstein E; Koch CJ
Cancer Res; 2002 Dec; 62(24):7273-9. PubMed ID: 12499269
[TBL] [Abstract][Full Text] [Related]
13. In vivo resistance to photofrin-mediated photodynamic therapy in radiation-induced fibrosarcoma cells resistant to in vitro Photofrin-mediated photodynamic therapy.
Adams K; Rainbow AJ; Wilson BC; Singh G
J Photochem Photobiol B; 1999 Apr; 49(2-3):136-41. PubMed ID: 10392463
[TBL] [Abstract][Full Text] [Related]
14. Interaction of photodynamic therapy and hyperthermia: tumor response and cell survival studies after treatment of mice in vivo.
Henderson BW; Waldow SM; Potter WR; Dougherty TJ
Cancer Res; 1985 Dec; 45(12 Pt 1):6071-7. PubMed ID: 4063964
[TBL] [Abstract][Full Text] [Related]
15. Hyperoxygenation enhances the tumor cell killing of photofrin-mediated photodynamic therapy.
Huang Z; Chen Q; Shakil A; Chen H; Beckers J; Shapiro H; Hetzel FW
Photochem Photobiol; 2003 Nov; 78(5):496-502. PubMed ID: 14653582
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
[TBL] [Abstract][Full Text] [Related]
17. Treatment-induced changes in tumor oxygenation predict photodynamic therapy outcome.
Wang HW; Putt ME; Emanuele MJ; Shin DB; Glatstein E; Yodh AG; Busch TM
Cancer Res; 2004 Oct; 64(20):7553-61. PubMed ID: 15492282
[TBL] [Abstract][Full Text] [Related]
18. A green fluorescent protein-expressing murine tumour but not its wild-type counterpart is cured by photodynamic therapy.
Castano AP; Liu Q; Hamblin MR
Br J Cancer; 2006 Feb; 94(3):391-7. PubMed ID: 16421588
[TBL] [Abstract][Full Text] [Related]
19. Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow.
Chan WS; Brasseur N; La Madeleine C; van Lier JE
Anticancer Res; 1996; 16(4A):1887-92. PubMed ID: 8712717
[TBL] [Abstract][Full Text] [Related]
20. Long-term regression of the murine mammary adenocarcinoma, LM3, by repeated photodynamic treatments using meso-tetra (4-N-methylpyridinium) porphine.
Colombo LL; Vanzulli SI; Villanueva A; Cañete M; Juarranz A; Stockert JC
Int J Oncol; 2005 Oct; 27(4):1053-9. PubMed ID: 16142323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
